+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Enveric Biosciences

ENVBNASDAQ

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.504600

0.037.36%

Last update: 11:14 AM

15 minutes delayed

Enveric Biosciences (ENVB) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Enveric Biosciences (NASDAQ:ENVB) Stock

Enveric Biosciences Stock (NASDAQ: ENVB)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, July 16, 2024

'MDMA Therapy Gets Support From Prominent Res...
Benzinga Newsdesk

Monday, July 15, 2024

Aries Science & Technology And Enveric Biosci...
Benzinga Newsdesk

Thursday, July 11, 2024

New Patented Psychedelic Drug Brings Hope For Brain Disorder Therapies
Juan Spínelli

Wednesday, July 10, 2024

Enveric Biosciences Expands Protection For EB...
Benzinga Newsdesk

Tuesday, June 25, 2024

Enveric Biosciences Elevates EB-003 To Lead D...
Benzinga Newsdesk

Wednesday, June 12, 2024

'Oregon's First-In-Nation Psilocybin Industry...
Benzinga Newsdesk

Thursday, May 23, 2024

On May 21, Enveric Biosciences Received Lette...
Benzinga Newsdesk

Thursday, May 16, 2024

'Psychedelics-Inspired' Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand
Jelena Martinovic

Wednesday, May 15, 2024

Enveric Biosciences Q1 2024 GAAP EPS $(0.61) ...
Benzinga Newsdesk

Tuesday, May 14, 2024

Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate
Nina Zdinjak

Wednesday, May 08, 2024

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
Nina Zdinjak

Tuesday, May 07, 2024

"FDA Expert Committee Will Review MDMA-Assist...
Benzinga Newsdesk

Wednesday, April 17, 2024

Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Lara Goldstein

Wednesday, April 03, 2024

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights

Tuesday, April 02, 2024

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights

Friday, March 29, 2024

Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Lara Goldstein

Wednesday, March 27, 2024

Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth
Lara Goldstein

Wednesday, March 20, 2024

Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Lara Goldstein

Tuesday, March 19, 2024

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Enveric Biosciences Canada Granted U.S. Patent #11931338: Nitrilated psilocybin derivatives and methods of using
Charles Gross
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Nasdaq Down 100 Points; US Housing Starts Surge In February
Avi Kapoor
Why Is Anxiety/Addiction-Focused Enveric Biosciences Stock Trading Higher Tuesday?
Vandana Singh
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Enveric Biosciences shares are trading higher...
Benzinga Newsdesk
The Non-pharmaceutical Application Term Sheet...
Benzinga Newsdesk
The Pharmaceutical Application Term Sheet Pro...
Benzinga Newsdesk
Enveric Biosciences Signed Two Non-binding Te...
Benzinga Newsdesk

Saturday, March 16, 2024

Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
Lara Goldstein

Thursday, March 14, 2024

Reported Earlier, 'Indiana Lawmakers Send Psi...
Benzinga Newsdesk

Tuesday, March 12, 2024

Enveric Biosciences Says On March 5, The Unit...
Benzinga Newsdesk

Tuesday, March 05, 2024

Enveric Biosciences Canada Awarded U.S. Patent #11918594: Multi-substituent Psilocybin Derivatives And Methods Of Using
Charles Gross

Monday, March 04, 2024

Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Lara Goldstein

Thursday, February 29, 2024

S&P 500 Moves Higher; Hayward Holdings Shares Jump On Upbeat Results
Avi Kapoor
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Crude Oil Moves Higher; Best Buy Posts Upbeat Earnings
Avi Kapoor
Enveric Biosciences shares are trading higher...
Benzinga Newsdesk
Why Enveric Biosciences Stock Is Soaring
Erica Kollmann
Nasdaq Gains 100 Points Following PCE Data
Avi Kapoor
Market-Moving News for February 29th
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug Compounds
Lara Goldstein

Friday, February 23, 2024

Enveric Biosciences Sells Cancer Patents As It Paves Way For Mental Health Treatments
Jelena Martinovic
Enveric Biosciences shares are trading higher...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Enveric Biosciences Says It Has Agreed To Se...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved